Efficacy and safety of rucaparib maintenance treatment in patients from ARIEL3 with platinum-sensitive, recurrent ovarian carcinoma not associated with homologous recombination deficiency
Coleman, R. L. Oza, A. M. Lorusso, D. Aghajanian, C. Oaknin, A. Dean, A. Colombo, N. Weberpals, J. I. Clamp, Andrew R Scambia, G.
Coleman, R. L.
Oza, A. M.
Lorusso, D.
Aghajanian, C.
Oaknin, A.
Dean, A.
Colombo, N.
Weberpals, J. I.
Clamp, Andrew R
Scambia, G.
Citations
Altmetric:
Abstract
Affiliation
Description
Date
2022
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Coleman RL, Oza AM, Lorusso D, Aghajanian C, Oaknin A, Dean A, et al. Efficacy and safety of rucaparib maintenance treatment in patients from ARIEL3 with platinum-sensitive, recurrent ovarian carcinoma not associated with homologous recombination deficiency. Journal of Clinical Oncology. 2022 Jun;40(16). PubMed PMID: WOS:000863680301600.